不可思议 发表于 2025-3-25 05:43:11

http://reply.papertrans.cn/24/2395/239402/239402_21.png

GOAT 发表于 2025-3-25 11:27:22

http://reply.papertrans.cn/24/2395/239402/239402_22.png

scotoma 发表于 2025-3-25 14:22:50

http://reply.papertrans.cn/24/2395/239402/239402_23.png

的事物 发表于 2025-3-25 19:26:55

http://reply.papertrans.cn/24/2395/239402/239402_24.png

perimenopause 发表于 2025-3-25 23:18:46

http://reply.papertrans.cn/24/2395/239402/239402_25.png

TEN 发表于 2025-3-26 00:53:41

http://reply.papertrans.cn/24/2395/239402/239402_26.png

sigmoid-colon 发表于 2025-3-26 05:47:14

http://reply.papertrans.cn/24/2395/239402/239402_27.png

收养 发表于 2025-3-26 12:17:07

Legal and Economic Analysis of Parallel Imports, of the re-imported pharmaceutical product. However, the question as to whether it is optimal for the manufacturer to charge the monopoly price in the home country depends on the level of trade costs and the level of heterogeneity of the two countries, in terms of market size and price elasticity of demand.

不适 发表于 2025-3-26 16:20:02

http://reply.papertrans.cn/24/2395/239402/239402_29.png

deface 发表于 2025-3-26 20:08:59

http://reply.papertrans.cn/24/2395/239402/239402_30.png
页: 1 2 [3] 4
查看完整版本: Titlebook: Creating R&D Incentives for Medicines for Neglected Diseases; An Economic Analysis Frank Müller-Langer Book 2009 Gabler Verlag | Springer F